SecBot SecBot
6-K ·Filed Jul 22, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001575872-26-000518
Actionable Insight • Neutral

Wait for readable filings or news from the company to assess any material events. The pair of 6-Ks filed on the same day with multiple exhibits suggests potential disclosures, but without legible content no trading action is justified.

DirectionNeutral
Confidencelow
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$11.38
T+0 close · Jul 22, 2026 · via day close
Latest settled
+13.36%
T+60 · $12.90
Vs SPY
+10.09%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 22 $11.38entry
  2. T+1 · 4mo ago +3.69%α +4.93% · $11.80
  3. T+5 · 4mo ago +3.34%α +5.74% · $11.76
  4. T+20 · 3mo ago +6.41%α +3.52% · $12.11
  5. T+60 · 5w ago +13.36%α +10.09% · $12.90
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two 6-K filings from Dr. Reddy's Laboratories filed on July 22, 2026, each contain exhibits (PDF, HTML, and graphics) whose content is unavailable for analysis due to encoding/truncation. Analysis based on filing metadata only, no material financial or corporate events can be identified from the unreadable documents.

Key Facts

  • Two 6-K filings (Form 6-K) filed on same day (2026-07-22) by Dr. Reddy's Laboratories
  • Exhibits include a PDF (EX-99.1) in first 6-K and an HTML + three JPG graphics in second 6-K
  • Document content is unreadable in the provided text, no financial figures or material disclosures can be extracted
  • Prior filing context: annual 20-F filed 54 days ago was neutral with no material changes

Financial Impact

Cannot be determined, filing content unavailable

Risk Factors

  • Unknown content risk: exhibits may contain material information that could move the stock
  • Low confidence due to unreadable filing text

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (RDY), Batch item 10001575872-26-000518
Document: 0001575872-26-000518-index.html0001575872-26-000516
Document: 0001575872-26-000518.txt0001575872-26-000518
6-K Filing (RDY), Batch item 40001575872-26-000516

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 22, 2026